Immature thymocyte antigen, JL1, as a possible immunodiagnostic and immunotherapeutic target for leukemia
Year: 2001
Type: article
Abstract: The identification of tumor-specific antigens has represented a critical milestone in cancer diagnosis and therapy. \nClinical research in this area for leukemia has also been driven over the past few decades by the hope that surface \nantigens with restricted tissue expression would be identified. Disappointingly, only a small number of the \nleukemic antigens identified to date, meet sufficient criteria to be considered viable immunophenotypic markers. \nIn this paper, we nominate anti-JL1 monoclonal antibody as an immunodiagnostic and immunotherapeutic \ncandidate for leukemia. The JL1 molecule appears to be a novel cell surface antigen, which is strictly confined \nto a subpopulation of limited stages during the hematopoietic differentiation process. Despite the restricted \ndistribution of the JL1 antigen in normal tissues and cells, anti-JL1 monoclonal antibody specifically recognizes \nvarious types of leukemia, irrespective of immunophenotypes. On the basis of these findings, we propose JL1 \nantigen as a tumor-specific marker, which shows promise as a candidate molecule for diagnosis and \nimmunotherapy in leukemia, and one that spares normal bone marrow stem cells.
Source: Immune Network
Institution: Seoul National University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W2014699444
